| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |